LYFT vs ZYME · P/E 108, rev $5.79B vs rev $76.3M
LYFT Inc (LYFT) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
LYFT Inc (LYFT) is a software - application company listed on US. It is led by David Risher.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported LYFT revenue for 2024-12-31 was $5.79B. Net income was $22.8M. Revenue was up 31.4% from 2023-12-31 to 2024-12-31. LYFT currently screens at market cap $6.79B and trailing P/E 107.7.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
LYFT currently screens at market cap $6.79B and trailing P/E 107.7. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the LYFT and ZYME stock pages for the full models.
Not investment advice.